Connect with us

Hi, what are you looking for?


Duterte signs COVID vaccine emergency use

PRESIDENT Rodrigo R. Duterte has signed the executive order granting the emergency approval on coronavirus disease 2019 (COVID-19) medicines and vaccines.

On Wednesday, the Palace released EO No. 121, which allows the Food and Drugs Administration (FDA) to issue emergency use authorization (EUA) to coronavirus drugs and vaccines.

“Outside clinical trials and except in cases where a Compassionate Special Permit is issued, no unregistered COVID-19 drug and vaccine may be manufactured, sold, imported, exported, distributed or transferred without an EUA,” the EO states.

Mr. Duterte last month approved in principle the recommendation of the Department of Health (DoH) for EUAs.

An EUA will be issued and remain valid if there is evidence that the drug or vaccine is effective in diagnosing, treating, or preventing the coronavirus; the potential benefits of the COVID-19 drug or vaccine outweigh the risks; and there is no available or not enough alternatives to the drug or vaccine.

Earlier on Wednesday, Secretary Carlito G. Galvez Jr., designated as the country’s vaccine czar, said vaccines could possibly be procured as early as the first quarter 2021.

He was referring in particular to vaccines from China’s Sinovac Biotech Ltd. and Russia’s Gamaleya Research Institute of Epidemiology and Microbiology.

“There is a possibility that our best-case scenario will be shifted to the first quarter. Our best-case scenario that we have presented is more or less May but for now, if we will succeed in negotiating with two to three vaccines from different countries, we might be able to get it during the first quarter,” he said in a briefing.

The government is prioritizing its COVID-19 vaccine purchase from four firms: Sinovac, Gamaleya, AstraZeneca plc, and Pfizer, Inc.

Mr. Galvez also said they are currently in negotiations with other foreign firms, including four US vaccine developers.

He assured that the government is doing its best to acquire vaccines amid the global demand and insufficient supply.

He said around 80% of vaccines have already been pre-purchased by developed countries while 2% were bought by the World Health Organization (WHO) for its Solidarity Trials.

Ang naiwan na lang po talaga sa atin (What is left for us) is 18% and there is really an acute source or supply of vaccine,” he said.

The Philippines has the second highest number of COVID-19 cases among southeast Asian countries, and experts have warned of a potential surge during the December holidays.   

The Health department reported 1,438 new coronavirus infections on Wednesday, bringing the total to 434,357.

The death toll rose by 18 to 8,436 while recoveries increased to 399,005 with 232 more patients who have gotten well, it said in a bulletin.

There were 26,916 active cases, 84.7% of which were mild, 7.1% did not show symptoms, 5.2% were critical, 2.7% were severe, and 0.29% were severe.

Davao City reported the highest number of new cases at 142, followed by Laguna at 89, Quezon City at 80, Manila at 63, and Pampanga at 63.

The department said six duplicates were removed from the total cases count and six recovered cases were reclassified as deaths.

Eleven laboratories failed to submit their data on Dec. 1.

About 5.5 million individuals have been tested for coronavirus, according to the agency’s COVID-19 tracker website. Around 64.2 million people have been infected and around 1.5 million people died of coronavirus globally, according to the Worldometers website, which cited various sources including data from the World Health Organization.

About 44.5 million people have recovered, it said. — Gillian M. Cortez and Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



THE BANGKO SENTRAL ng Pilipinas (BSP) sees the country posting a wider balance of payments (BoP) deficit this year as the global outlook remains...


HMRC’s new penalty regime for late filing and late payments of VAT will be fairer but more complex with interest being charged on all...


Economic managers said they “strongly support” the creation of the Maharlika Wealth Fund (MWF), after lawmakers agreed to remove a provision in the bill...


If you’ve been waiting ages for an online order to arrive, you’re not alone. Companies including ASOS, H&M and JD Sports have been getting...


Ulster University economists expect the Northern Ireland economy to shrink next year, followed by a weak recovery in 2024. The Ulster University Economic Policy...


The number of people working in programming and computer consultancy has risen by more than 250,000 workers over the past decade, according to Census...

You May Also Like


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Browsing history makes referring to sites and pages you’ve visited in the past seamless. It’ll help you recall what page you checked out on...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.